A Vision for Growth

Capital, innovation, and the next wave of ophthalmic breakthroughs

1

Ophthalmology is experiencing a surge in innovation, with new treatments for conditions like AMD and myopia moving from concept to clinical trials.
2

The global ophthalmology drug market is projected to grow from $38 billion in 2024 to $62 billion by 2030, indicating strong investment potential.
3

Cell and gene therapies are at the forefront of ophthalmic innovation, offering potential one-time treatments for various sight-threatening conditions.
4

Rising demand for clinical trials in ophthalmology is expected to reach $2.5 billion by 2030, reflecting a compound annual growth rate of 6.6%.
5

Collaborative efforts among stakeholders, including consortia, are essential for advancing ophthalmic innovations and ensuring successful outcomes.

1